Attached files
| file | filename |
|---|---|
| S-1/A - S-1/A2 - Immunoclin Corp | pharmas1a2.htm |
| EX-5 - EX 5.1 LEGAL OPINION AND CONSENT - Immunoclin Corp | pharmas1a2ex51.htm |
| EX-10 - EX 10.4 PROMISSORY NOTE - Immunoclin Corp | pharmas1a2ex104.htm |
| EX-10 - EX 10.3 PROMISSORY NOTE - Immunoclin Corp | pharmas1a2ex103.htm |
Exhibit 23.1
SADLER, GIBB & ASSOCIATES, L.L.C.
Registered with the Public Company
Accounting Oversight Board
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors
Pharma Investing News, Inc.
As independent registered public accountants, we hereby consent to the use of our report dated May 6, 2011, with respect to the financial statements of Pharma Investing News, Inc. in its registration statement on Form S-1 relating to the registration of 4,000,000 shares of common stock. We also consent to the reference of our firm under the caption “interests of name experts and counsel” in the registration statement.
/s/ Sadler, Gibb & Associates, LLC
Sadler, Gibb & Associates, LLC
Salt Lake City, UT
August 29, 2011